We are live on ! Find out more
HI

HBK Investments Portfolio holdings

AUM $9.85B
1-Year Est. Return 55.6%
This Fund
S&P 500
This Quarter Est. Return
+31.23%
1 Year Est. Return
+55.6%
3 Year Est. Return
+156.38%
5 Year Est. Return
+423.64%
10 Year Est. Return
+2,347.17%
AUM
$2.37B
AUM Growth
-$11.7B
Cap. Flow
-$11.4B
Cap. Flow %
-481.89%
Top 10 Hldgs %
86.27%
Holding
391
New
7
Increased
7
Reduced
1
Closed
376

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 16.93%
3 Real Estate 15.53%
4 Energy 9.66%
5 Utilities 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOACW
376
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
-448,948
Closed -$4K
IS
377
DELISTED
ironSource Ltd.
IS
-12,145,356
Closed -$41.8M
HAAC
378
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
-682,833
Closed -$6.82M
LUXA
379
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
-553,700
Closed -$5.54M
PAQC
380
DELISTED
Provident Acquisition Corp. Class A Ordinary Shares
PAQC
-225,000
Closed -$2.25M
PIPP
381
DELISTED
Pine Island Acquisition Corp.
PIPP
-390,500
Closed -$3.9M
TWTR
382
CALL
DELISTED
Twitter, Inc.
TWTR
-2,652,000
Closed -$116M
TWTR
383
DELISTED
Twitter, Inc.
TWTR
-1,733,105
Closed -$76M
TWTR
384
PUT
DELISTED
Twitter, Inc.
TWTR
-1,036,200
Closed -$45.4M
ENPC
385
DELISTED
Executive Network Partnering Corporation
ENPC
-1,279,738
Closed -$12.8M
HIGA
386
DELISTED
H.I.G. Acquisition Corp.
HIGA
-459,751
Closed -$4.61M
AVLR
387
DELISTED
Avalara, Inc.
AVLR
-4,000,000
Closed -$367M
NLSN
388
DELISTED
Nielsen Holdings plc
NLSN
-3,300,000
Closed -$91.5M
NLSN
389
PUT
DELISTED
Nielsen Holdings plc
NLSN
-530,900
Closed -$14.7M
BLEU
390
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
-503,181
Closed -$4.96M
BHVN
391
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-3,550,000
Closed -$537M

Similar funds

HBK Investments's Q4 2022 Portfolio in Review

As of Q4 2022, HBK Investments held 391 positions worth $2.37B, down 83% from $14.1B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

HBK Investments withdrew a net $11.4B in Q4 2022, closing 376 positions and reducing 1 holding. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $537M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 4.1% a quarter earlier, followed by Technology and Real Estate.

Against the trend, HBK Investments opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $521M.

  • HBK Investments's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 4,576,000 shares worth $521M.
  • HBK Investments added most to STORE Capital Corporation in Q4 2022, an estimated $315M increase.
  • HBK Investments's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $33.4M.
  • HBK Investments fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $537M.
  • HBK Investments's ten largest holdings make up 86% of its $2.37B portfolio in Q4 2022.
  • HBK Investments opened 7 new positions and closed 376 in Q4 2022.
  • HBK Investments's portfolio value fell 83% quarter-over-quarter to $2.37B.

Based on HBK Investments's 13F filing for Q4 2022, filed 14 Feb 2023.